We have set up our new Discord server! Share your feedback and find like-minded people! Join our Discord

Ticker
CLPT

Price
23.68
Stock movement down
-0.43 (-1.78%)
Company name
Clearpoint Neuro Inc
Exchange
(NASDAQ
,
Currency
USD
)
Sector
Healthcare >
Medical Devices
Market cap
673.16M
Ent value
662.78M
Price/Sales
22.12
Price/Book
23.21
Div yield
-
Div growth
-
Growth years
-
FCF payout
-
Trailing P/E
-
Forward P/E
-
PEG
-
EPS growth
9.74%
1 year return
80.08%
3 year return
-
5 year return
-
10 year return
-
Last updated: 2025-10-30

iO Charts is a Seeking Alpha partner

DIVIDENDS

CLPT does not pay dividends or no data was received

iO Charts is a Seeking Alpha partner

iO Charts is a Seeking Alpha partner

VALUATION

Valuation Ratios

Loading...
Valuation Ratios data
Trailing P/E-
Price to OCF-
Price to FCF-
Price to EBITDA-
EV to EBITDA-

Valuation (Sales/Book Value)

Loading...
Valuation (Sales/Book Value) data
Price to Sales22.12
Price to Book23.21
EV to Sales21.78

FINANCIALS

Per share

Loading...
Per share data
Current share count28.43M
EPS (TTM)-
FCF per share (TTM)-

Income statement

Loading...
Income statement data
Revenue (TTM)-
Gross profit (TTM)-
Operating income (TTM)-
Net income (TTM)-
EPS (TTM)-
EPS (1y forward)-0.68

Margins

Loading...
Margins data
Gross margin (TTM)-
Operating margin (TTM)-
Profit margin (TTM)-

Balance Sheet

Loading...
Please create a free account or log in to access this chart
Balance Sheet data
Cash38.22M
Net receivables4.00M
Total current assets51.33M
Goodwill0.00
Intangible assets0.00
Property, plant and equipment0.00
Total assets60.36M
Accounts payable723.00K
Short/Current long term debt6.54M
Total current liabilities8.05M
Total liabilities44.48M
Shareholder's equity0.00
Net tangible assets0.00

Cash flow

Loading...
Please create a free account or log in to access this chart
Cash flow data
Operating cash flow (TTM)-
Capital expenditures (TTM)-
Free cash flow (TTM)-
Dividends paid (TTM)-

Financial returns

Loading...
Please create a free account or log in to access this chart
Financial returns data
Return on Equity-
Return on Assets-
Return on Invested Capital-
Cash Return on Invested Capital-

iO Charts is a Seeking Alpha partner

STOCK INFORMATION

Stock chart

Loading...
Stock price data
Open23.87
Daily high24.98
Daily low23.55
Daily Volume472K
All-time high178.00
1y analyst estimate29.00
Beta0.98
EPS (TTM)-
Dividend per share0.00
Ex-div date-
Next earnings date11 Nov 2025

Downside potential

Loading...
Downside potential data
CLPTS&P500
Current price drop from All-time high-86.70%-1.10%
Highest price drop-94.38%-19.00%
Date of highest drop1 Aug 20258 Apr 2025
Avg drop from high-91.99%-2.76%
Avg time to new high-5 days
Max time to new high266 days89 days
COMPANY DETAILS
CLPT (Clearpoint Neuro Inc) company logo
Marketcap
673.16M
Marketcap category
Small-cap
Description
ClearPoint Neuro, Inc. operates as a medical device company primarily in the United States. It develops and commercializes platforms for performing minimally invasive surgical procedures in the brain under magnetic resonance imaging guided interventions. The company offers ClearPoint system, an integrated system for the insertion of deep brain stimulation electrodes, biopsy needles, and laser catheters, as well as the infusion of pharmaceuticals into the brain. It has license and collaboration agreement with Clinical Laserthermia Systems AB; license and research agreement with Koninklijke Philips N.V.; UCB Biopharma SRL; NE Scientific, LLC; and University of California, San Francisco, and Johns Hopkins University. The company was formerly known as MRI Interventions, Inc. and changed its name to ClearPoint Neuro, Inc. in February 2020. ClearPoint Neuro, Inc. was incorporated in 1998 and is headquartered in Solana Beach, California.
Employees
115
Investor relations
-
SEC filings
CEO
Joseph Michael Burnett
Country
USA
City
Irvine
Stock type
Common stock
CCC status
-
Dividend Frequency
-
EVENTS AND PRESENTATIONS
EventsPresentations
Loading...

iO Charts is a Seeking Alpha partner

iO Charts is a Seeking Alpha partner

UNDERSTAND THE BUSINESS
Loading...